Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Rapparini

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
American Journal of Clinical Dermatology|March 19, 2026
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World StudyMichela Starace, Luca Rapparini, Francesca Pampaloni, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
American Journal of Clinical Dermatology|March 19, 2026
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World StudyMichela Starace, Luca Rapparini, Francesca Pampaloni, et al.
Pageof 7